Back To Top
PRESS CONTACT
The World Drug Report is an annual publication of the United Nations Office on Drugs and Crime that analyses the global drug market and its societal impacts. The third booklet of the 2022 report, entitled "Drug Market Trends of Cannabis and Opioids", is the only section that deals with medical cannabis.
According to its own information, Drapalin will cooperate with Coliquio, the largest German-language information platform for doctors. For the first time, 190,000 physicians will have a new opportunity to obtain practical knowledge on the topic of medical cannabis and to exchange information together.
Drapalin now distributes PAX Labs 3 vaporizers in Germany and Demecan announces three new supply contracts. Our product update for the medical cannabis market.
Cosmopolitan magazine interviewed our CEO Lana Korneva in the March issue under the motto #SupportHer. With this monthly series, Cosmopolitan presents inspiring women. Why the Drapalin co-founder and CEO traded her successful financial career for one of the world's oldest medicinal plants, read here.
Munich - Since 2021, German pharmacies can rely on the stable and secure supply of medical cannabis from the experienced Munich-based wholesaler DRAPALIN. Orders for DRAPALIN cannabis flowers can be placed both directly with Drapalin Pharmaceuticals GmbH and, as of now, with pharmaceutical wholesalers Alliance Healthcare Deutschland GmbH and GEHE Pharma Handel GmbH.
The Ukrainian Ivan Garev, one of the founders of Drapalin, has been taking care of aid packages being sent to Ukraine since the beginning of the war. A special call directly from the war zone is crucial for our CBD oil aid package, which is already on its way to Ukraine.
DRAPALIN is now cooperating with coliquio, the largest German-language information platform for doctors. For the first time, 190,000 physicians have an exclusive opportunity to obtain practical knowledge on the topic of medical cannabis and to exchange information together.
Munich - Medical cannabis has already established itself as a therapy option for many clinical indications. Nevertheless, there are still many areas of application in which numerous patients are successfully treated with cannabis, but this has so far received little attention in research.
Berlin - Cannabis is playing an increasingly important role in pharmacies. In the past few years, new suppliers have joined the ranks. They all cultivate cannabis in pharmaceutical quality. The location and the type of cultivation influence the end product.
Where does big business lurk? When will legalisation take place and how is the German market for medical cannabis developing? After the euphoria of the last few years, hemp entrepreneurs and investors have become more pragmatic.
1 2 3
DRAPALIN is now cooperating with coliquio, the largest German-language information platform for doctors. For the first time, 190,000 physicians have an exclusive opportunity to obtain practical knowledge on the topic of medical cannabis and to exchange information together.
The wholesaler from Munich now has the first EU-GMP compliant medical cannabis strain from Africa in its portfolio. The medical cannabis produced in the landlocked South African country of Lesotho is currently imported exclusively by DRAPALIN to Germany.
DRAPALIN Pharmaceuticals GmbH bietet im Jahr 2021 eine Reihe kostenfreier CME-zertifizierter Webinare zum Thema „Medizinisches Cannabis“ an. Das Großhandelsunternehmen hat sich damit zum Ziel gesetzt, nicht nur die Verfügbarkeit von hochqualitativem medizinischem Cannabis auf dem deutschen Markt auszubauen, sondern auch umfassende Fachinformationen für Ärzte, Apotheker und interessiertes medizinisches Fachpersonal anzubieten.

Die Fortbildungsreihe beginnt am 20.01.2021 um 18:00 Uhr mit einem Webinar von Dr. med. Stephan Konrad zum Thema „Cannabis und Cannabinoide bei Schmerz – Von der Indikation zur Therapie in der Praxis“. Diese Fortbildung ist von der Bayerischen Landesärztekammer (BLÄK) mit 2 CME-Punkten zertifiziert.
Many people are aware that medical cannabis is a medicine that can be used to treat a wide range of conditions. What is less well known, however, is that there are many different varieties of medical cannabis that have different effects and can thus be used for different diseases. About 700 varieties have been named and described (1). Which cannabis strain is best for a patient depends on factors such as the cannabinoid and terpene profile of the strain and the condition being treated.
No danger of recourse for doctors when prescribing cannabis Since March 2017, doctors have been allowed to prescribe medical cannabis for therapeutic purposes on a BtM-prescription. The prerequisite for this is that the medical cannabis is produced under state supervision. For this purpose, lawmakers have amended several regulations with the law known as the "Cannabis Law". Cannabis is now a narcotic that can be traded and prescribed according to Annex III of the BtM-Act. However, this is only the case if a cannabis agency supervises its production.
Hemp oil is an edible oil obtained by the cold pressing of hemp seeds. It contains several ingredients and active substances that can promote health and well-being. Hemp seed oil has probably been used by humans for around 10,000 years and has recently been gaining popularity as a potentially beneficial addition to skin and hair care. Non-psychoactive and rich in high-quality nutrients, hemp seed oil has a balanced composition of essential fatty acids such as omega 3 and 6, as well as linoleic acid.
With the entry into force of the "Cannabis as Medicine" Act on 10 March 2017, the possibilities for prescribing cannabis medicines were expanded. This means that medicinal cannabis flowers have become reimbursable by the statutory health insurance funds under certain preconditions.[1] Medical cannabis has since then increasingly become the focus of public interest. How can patients benefit from cannabis-based medicines for various diseases? How and where can one get a prescription? What advice should one follow? This article provides answers to these and other questions and offers an up-to-date overview.
PRESS CONTACT
DRAPALIN Logo